Bortezomib overcomes MGMT-related resistance of glioblastoma cell lines to temozolomide in a schedule-dependent manner.
about
Characterization of a novel anti-cancer compound for astrocytomasTowards precision medicine-based therapies for glioblastoma: interrogating human disease genomics and mouse phenotypesIdentification of imaging biomarkers for the assessment of tumour response to different treatments in a preclinical glioma model.Impairment of stress granule assembly via inhibition of the eIF2alpha phosphorylation sensitizes glioma cells to chemotherapeutic agents.Mitochondrial Impairment May Increase Cellular NAD(P)H: Resazurin Oxidoreductase Activity, Perturbing the NAD(P)H-Based Viability Assays.The prognosis of MGMT promoter methylation in glioblastoma patients of different race: a meta-analysis.Phase I trial of dose-escalating metronomic temozolomide plus bevacizumab and bortezomib for patients with recurrent glioblastoma.The Clinical Significance of O6-Methylguanine-DNA Methyltransferase Promoter Methylation Status in Adult Patients With Glioblastoma: A Meta-analysis.Hypoxia-mediated mitochondria apoptosis inhibition induces temozolomide treatment resistance through miR-26a/Bad/Bax axis
P2860
Q28543237-2FBDE83A-8D0E-46B2-8660-679BE0704E17Q36111611-36812E58-FE28-47A9-9E1F-A816C94975B3Q38894617-E2D297C4-42C3-4185-A537-F7AFCFCD95F0Q40144356-0B7652AC-EB7E-461A-94B6-4CA61E22B63DQ41616449-7AE8001F-AA9A-4046-904B-F5E8E04E6457Q45835773-164CE9A9-BF38-46DB-AD6B-E7AFEC91340DQ48473042-9454FC92-152D-4E3A-AFA6-62C7121C5C6AQ52606179-9D589415-83BE-4D41-929D-6F72442F4E81Q59133407-D4BBC97E-CA01-462D-A060-230E2A0A1C2C
P2860
Bortezomib overcomes MGMT-related resistance of glioblastoma cell lines to temozolomide in a schedule-dependent manner.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Bortezomib overcomes MGMT-rela ...... n a schedule-dependent manner.
@en
Bortezomib overcomes MGMT-rela ...... n a schedule-dependent manner.
@nl
type
label
Bortezomib overcomes MGMT-rela ...... n a schedule-dependent manner.
@en
Bortezomib overcomes MGMT-rela ...... n a schedule-dependent manner.
@nl
prefLabel
Bortezomib overcomes MGMT-rela ...... n a schedule-dependent manner.
@en
Bortezomib overcomes MGMT-rela ...... n a schedule-dependent manner.
@nl
P2093
P2860
P1476
Bortezomib overcomes MGMT-rela ...... in a schedule-dependent manner
@en
P2093
Christina D Befani
Christos N Papandreou
Eleana Hatzidaki
Panagiotis J Vlachostergios
P2860
P2888
P304
P356
10.1007/S10637-013-9968-1
P50
P577
2013-05-05T00:00:00Z